Which of the following about nerve conduction velocity is not true?
---
- (A) Nerve conduction velocity at birth is half of the normal mature values
- (B) Mature values of NCV are achieved by the age of 3 years
- (C) Only the fastest conducting fibres are measured in the study of nerve conduction velocity
- (D) Only the fastest conducting fibres are measured in the study of nerve conduction velocity
💡 Click to Reveal Answer & Nelson Rationale
Option B (Mature values of NCV are achieved by the age of 3 years)
Nerve conduction velocity (NCV) is a key indicator of peripheral nerve maturation, largely
dependent on myelination and axon diameter. At birth, due to incomplete myelination, NCV
is approximately 50% of adult values. Nelson states that mature NCV is typically achieved by
around 2 years of age, not 3. Therefore, the statement that mature values are reached by 3
years is not accurate and makes this the incorrect statement in the given options.
This distinction is clinically important when interpreting pediatric nerve conduction studies,
where age-specific normative values must be used.
A 7-year-old boy with Duchenne Muscular Dystrophy (DMD) is found to have a mutation
amenable to exon 53 skipping. Which of the following medications is designed to promote
skipping of exon 53 in this patient?
---
- (A) Eteplirsen
- (B) Casimersen
- (C) Golodirsenv
- (D) Ataluren
💡 Click to Reveal Answer & Nelson Rationale
Option C (Golodirsenv)
Exon-skipping drugs are antisense oligonucleotide sequences (ASOs) which can cross the nucleus of the muscle cell, attach to the splicing sites of pre-mRNA, resulting in the targeted deletion of that exon. Golodirsen is an antisense oligonucleotide (ASO) designed to bind to exon 53 of the dystrophin pre-mRNA. This binding triggers exon 53 to be skipped during mRNA processing, resulting in a shortened, but partially functional, dystrophin protein. It is specifically indicated for patients with DMD who have mutations amenable to exon 53 skipping. Another ASO that binds to exon 53 of the dystrophin pre-mRNA is Viltolarsen.
Both deficiency and excess of what causes myopathy?
---
- (A) Vitamin E
- (B) Pyridoxine
- (C) Thiamine
- (D) Vitamin B12
💡 Click to Reveal Answer & Nelson Rationale
Option A (Vitamin E)
Vitamin E (α-tocopherol) is a crucial antioxidant, especially important in mitochondrial superoxide regulation and protecting muscle membranes from oxidative injury. Deficiency of vitamin E can lead to progressive proximal muscle weakness, hyporeflexia, ataxia, ophthalmoplegia (in severe cases). It often affects patients with chronic malabsorption, long-term dialysis, or premature infants not given supplements. Myopathy caused by chronic hypervitaminosis E also occurs. This makes Vitamin E unique, as both deficiency and chronic overdose can cause myopathy.
Paramyotonia is seen in -
---
- (A) Sodium channelopathy
- (B) Chloride channelopathy
- (C) Potassium channelopathy
- (D) Calcium channelopathy
💡 Click to Reveal Answer & Nelson Rationale
Option A (Sodium channelopathy)
Paramyotonia congenita is a non-dystrophic myotonia characterized by worsening stiffness with repeated activity and cold exposure. It is caused by mutations in the SCN4A gene, which encodes the α-subunit of the skeletal muscle voltage-gated sodium channel (NaV1.4). This mutation leads to delayed inactivation of the sodium channel, causing persisten depolarization and muscle stiffness. Clinically, paramyotonia differs from myotonia congenita by being paradoxical as stiffness worsens with repetition and cold, rather than improving (unlike in classic warm-up phenomenon of myotonia congenita).
Which of the following does not cause demyelinating neuropathy?
---
- (A) MFN2
- (B) PMP22
- (C) X-linked Adrenoleukodystrophy
- (D) Metachromatic Leukodystrophy
💡 Click to Reveal Answer & Nelson Rationale
Option A (MFN2)
Peripheral neuropathies can be broadly classified into demyelinating (affecting the myelin sheath) and axonal. Demyelinating neuropathies show markedly reduced nerve conduction velocities, while axonal neuropathies usually present with normal velocities and reduced amplitude. MFN2 refers to Mitofusin genes, which is commonly mutated in Charcot-Marie-Tooth disease type 2A (CMT2A). CMT2A is a primary axonal neuropathy, not a demyelinating one. MFN2 is involved in mitochondrial fusion and transport, and its mutation leads to axonal degeneration in peripheral nerves. Thus, MFN mutations cause axonal neuropathies, not demyelinating neuropathies
PMP22 is not related to which of the following
---
- (A) CMT1
- (B) CMT2
- (C) CMT3
- (D) Tomaculous neuropathy
💡 Click to Reveal Answer & Nelson Rationale
Option B (CMT2)
Charcot-Marie-Tooth diseases (CMTDs) are a group of hereditary motor and sensory neuropathies characterized by chronic distal muscle weakness, atrophy, and sensory loss. They are broadly classified into demyelinating types (CMT1, CMT3) and axonal types (CMT2) based on nerve conduction studies. Among the most common genetic causes of demyelinating CMT, the PMP22 gene (Peripheral Myelin Protein 22) plays a central role. PMP22 is a gene crucial for myelin sheath formation and maintenance in the peripheral nervous system. Charcot-Marie-Tooth disease type 2 (CMT2) is an axonal neuropathy. It primarily involves degeneration of the axons rather than the myelin sheath. PMP22 gene mutations do not cause axonal neuropathies like CMT2. Instead, CMT2 is most commonly caused by mutations in genes like MFN2, GARS, TRPV4, etc.
A 5-month-old infant presents with progressive hypotonia, weak cry, poor head control, and difficulty feeding. The cry and cough are weak, and tongue fasciculations are noted. Deep tendon reflexes are absent in all limbs, but sensory responses are preserved. Genetic testing confirms homozygous deletion of SMN1 (SMA type 1). The parents ask about treatments that can slow disease progression. Which of the following is the most appropriate first-line therapy?
---
- (A) Oral prednisolone
- (B) Nusinersen
- (C) Supportive care only
- (D) ntravenous immunoglobulin (IVIG)
💡 Click to Reveal Answer & Nelson Rationale
Option B (Nusinersen)
Spinal muscular atrophy (SMA) is a disorder showing an autosomal recessive (AR) inheritance pattern. Based on its severity, it is classified into four clinical subtypes. Type I SMA or Werdnig-Hoffmann disease is the most severe form in which symptom onset occurs in utero or during early life, and patients cannot sit up unaided. Patients with type II or intermediate SMA can sit up unaided but can never ambulate. Type III SMA or Kugelberg-Welander syndrome manifests later in life, and patients can ambulate. Main symptoms include proximal muscle weakness, often associated with fasciculations and tremor. Type IV SMA is rare with late-onset disease manifesting in patients aged >35 years. The survival motor neuron (SMN) gene located on chromosome 5q is associated with SMA. There are two nearly identical genes called the telomeric SMN1 and tandemly duplicated centromeric SMN2 present at the locus. SMN2 is distinguished from SMN1 based on the difference in a single nucleotide that disrupts an exonic splice enhancer in exon 7 and results in lack of exon 7 and production of unstable and less functional proteins. Over 95% of patients show deletion of SMN1. A few patients with adult-onset disease may show mutations in SMN1 instead of deletion of SMN1. Symptom severity is inversely correlated with the number of copies of SMN2 in patients who lack SMN1. SMA type 1 is caused by loss of SMN1, leading to degeneration of anterior horn cells in the spinal cord. Infants present with floppy baby features, poor antigravity movements, weak cry, and feeding difficulties. The hallmark examination findings include generalized hypotonia, head lag, weak cry and cough, tongue fasciculations, and absent deep tendon reflexes, with preserved sensation. Early respiratory involvement may manifest as intercostal retractions. Recognizing these signs is crucial for early diagnosis and timely initiation of therapy. Untreated SMA type 1 usually leads to severe motor impairment and early mortality. SMN2 copy number modifies severity. Nusinersen is an intrathecal antisense oligonucleotide that modifies SMN2 splicing to increase functional SMN protein production. It is the first-line disease-modifying therapy for infants with SMA and has been shown to improve survival and motor outcomes. Other disease-modifying options include risdiplam (oral SMN2 modifier) and onasemnogene abeparvovec (gene therapy for children <2 years). Supportive care, including nutritional support, respiratory management, and physiotherapy, is essential but does not alter the disease course.
A 3-day-old term male infant, born to a mother with myasthenia gravis, presents with poor sucking, hypotonia, and weak cry. Which of the following statements about Transient Neonatal Myasthenia Gravis (TNMG) is correct?
---
- (A) TNMG occurs in 50–70% of infants born to mothers with MG.
- (B) TNMG is caused by maternal IgM antibodies crossing the placenta.
- (C) TNMG is self-limiting within weeks as maternal antibodies are cleared from the neonatal circulation.
- (D) TNMG cannot be caused by antibodies other than against acetylcholine receptors (AChR).
💡 Click to Reveal Answer & Nelson Rationale
Option C (TNMG is self-limiting within weeks as maternal antibodies are cleared from the neonatal circulation.)
Transient Neonatal Myasthenia Gravis (TNMG) is a passively acquired autoimmune disorder of the neonate that results from the transplacental transfer of maternal IgG autoantibodies against proteins of the neuromuscular junction. These antibodies impair neuromuscular transmission, leading to symptoms like hypotonia, weak cry, poor feeding, and in severe cases, respiratory distress. The disease typically presents in the first 1-3 days of life and affects about 10–20% of infants born to mothers with MG. Importantly, TNMG is self-limiting, as maternal antibodies are gradually degraded within weeks after birth, and most infants recover completely. It occurs due to maternal IgG antibodies, which have a half-life of about 2–3 weeks in neonatal circulation. As these antibodies are naturally degraded, the neuromuscular junction recovers and symptoms resolve. Most infants improve within 2–8 weeks. Majority require only supportive care and observation, though some may benefit from acetylcholinesterase inhibitors (e.g., pyridostigmine). Severe cases may require IVIG or plasmapheresis to accelerate antibody clearance. The long-term neuromuscular function is normal in most infants. Thus, self-resolution with time is the defining characteristic of TNMG.
A 14-year-old boy presents with recurrent episodes of flaccid weakness, often precipitated by heavy carbohydrate meals and rest after exercise. Serum potassium during attacks is found to be low. Which ion channel mutation is most commonly associated with this disorder?
---
- (A) Sodium channel
- (B) Calcium channel
- (C) Potassium channel
- (D) Chloride channel
💡 Click to Reveal Answer & Nelson Rationale
Option B (Calcium channel)
Periodic paralyses are a group of muscle channelopathies characterized by episodic flaccid weakness with normal strength between attacks. They are associated with transient alterations in serum potassium levels, usually hypokalemia but occasionally hyperkalemia. All familial forms of periodic paralysis are caused by pathogenic variants in genes encoding voltage- gated ion channels in muscle: sodium, calcium, and potassium. During attacks of hypokalemic paralysis, myofibers are electrically unexcitable, although the contractile apparatus can respond normally to calcium. The genetic disorder is inherited as an autosomal dominant trait. Episodes of hypokalemic paralysis often begin in late childhood or adolescence in the hypokalemic form. Periodic paralysis is an episodic event; patients are unable to move after awakening and gradually recover muscle strength during the next few minutes or hours. All four extremities are involved. Muscles that remain active in sleep, such as the diaphragm, extraocular muscles (rapid eye movements), and cardiac muscle are not affected. Patients are normal between episodes, but in adult life episodes become more frequent, and the disorder causes progressive myopathy with permanent weakness even between episodes. Hypokalemic periodic paralysis (HypoPP) is the most common form, often presenting in childhood/adolescence with attacks triggered by carbohydrate-rich meals or rest after exercise. It is most frequently caused by mutations in the CACNA1S gene (encoding L-type calcium channel α1-subunit), though SCN4A sodium channel mutations can also rarely cause HypoPP. Thus, the calcium channel defect is the classic association.
A 7-year-old boy with genetically confirmed Duchenne muscular dystrophy (DMD) has progressive difficulty climbing stairs and a positive Gowers’ sign. Which of the following statements about DMD is TRUE?
---
- (A) About half of patients lack calf hypertrophy.
- (B) Heart failure commonly presents while the child is still ambulatory.
- (C) Knee reflexes are typically lost earlier than ankle reflexes.
- (D) Dystrophin immunostaining shows reduced (but present) dystrophin in most fibres.
💡 Click to Reveal Answer & Nelson Rationale
Option C (Knee reflexes are typically lost earlier than ankle reflexes.)
Duchenne muscular dystrophy is an X-linked recessive muscle disease caused most commonly by out-of-frame deletions/duplications or nonsense mutations in the DMD gene on Xp21 that lead to absent or nearly absent dystrophin. Dystrophin is a large cytoskeletal protein that links the intracellular actin cytoskeleton to the sarcolemma and the extracellular matrix through the dystrophin–glycoprotein complex. Without dystrophin, muscle membranes are fragile, so repeated contraction causes fibre damage; over time, muscle is replaced by fat and connective tissue, leading to high CK levels and progressive weakness. Clinically, DMD usually presents between 2–5 years with delayed motor milestones or difficulty running, frequent falls, a waddling gait, and a positive Gowers’ sign. Calf pseudohypertrophy (apparent enlargement due to fat/fibrosis replacing muscle) is very common. Progression is relentless: most boys lose independent ambulation by early teens without treatment. The disease affects skeletal, respiratory and cardiac muscle - dilated cardiomyopathy develops in most patients and is a leading cause of morbidity and mortality. Respiratory muscle weakness is another major complication. Diagnosis rests on clinical picture, very high CK, genetic testing, and muscle biopsy/immunostaining only when genetic testing is inconclusive. Becker muscular dystrophy (BMD) is allelic but milder, caused by in-frame mutations producing reduced or abnormal dystrophin (truncated protein) and tends to have a later onset; importantly, severe cardiomyopathy may be relatively prominent in BMD and can present while patients remain ambulant. Unless ankle contractures are severe, ankle deep tendon reflexes remain preserved until terminal stages. The knee deep tendon reflexes may be present until about 6 years of age but are less brisk than the ankle jerks and are eventually lost with the progression of weakness. Hence option C is the correct choice.
A child presents with periodic muscle weakness, prolonged QT interval with ventricular arrhythmias, and dysmorphic features. Which of the following syndromes is most likely?
---
- (A) Andersen-Tawil Syndrome
- (B) Long QT syndrome type 1
- (C) Timothy syndrome
- (D) Hypokalemic periodic paralysis
💡 Click to Reveal Answer & Nelson Rationale
Option A (Andersen-Tawil Syndrome)
Andersen–Tawil syndrome is characterized by a classical triad: periodic paralysis, ventricular arrhythmias due to abnormal cardiac repolarization, and distinctive dysmorphic features. The periodic paralysis manifests as episodic flaccid weakness, often triggered by rest after exercise, fasting, or a high-carbohydrate meal. The cardiac manifestations include ventricular ectopy. On ECG, there may be a prolonged QU interval, with prominent U waves. Dysmorphic features are variably present and include low-set ears, micrognathia, hypertelorism, a broad nasal root, clinodactyly, scoliosis, and short stature. Genetically, most cases are due to autosomal dominant mutations in KCNJ2, which encodes the Kir2.1 potassium channel. Management involves avoidance of QT-prolonging drugs and hypokalemia, potassium supplementation during attacks, acetazolamide or dichlorphenamide to reduce the frequency of episodes, and anti-arrhythmic strategies including beta-blockers or flecainide. In severe cases with life-threatening arrhythmias, ICD placement may be considered.
Which of the following is a typical feature of Emery-Dreifuss Muscular Dystrophy (EDMD)?
---
- (A) Facial weakness with scapular winging
- (B) Early contractures of elbows and Achilles tendons
- (C) Tongue hypertrophy and loss of ambulation by early teens
- (D) Distal weakness with myotonia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Early contractures of elbows and Achilles tendons)
Emery–Dreifuss muscular dystrophy (EDMD) is a neuromuscular disorder with a characteristic triad: early joint contractures, slowly progressive muscle weakness and wasting, and cardiac conduction abnormalities. Among these, the early appearance of contractures, particularly of the elbows, Achilles tendons, and posterior neck muscles, is one of the most striking and distinctive clinical features. These contractures often present in childhood, sometimes even before muscle weakness becomes apparent, and may cause limitations in mobility. Muscle weakness typically follows a humeroperoneal distribution, initially affecting the muscles of the upper arms and lower legs, before gradually spreading to involve the shoulder and pelvic girdle muscles. Cardiac involvement is a major concern in EDMD. EDMD is caused by mutations in EMD (emerin, X-linked) or LMNA (lamin A/C, autosomal dominant/recessive).
A child presents with progressive pontobulbar palsy (facial weakness, dysphagia), sensorineural deafness, and later develops motor neuron disease–like features with diaphragmatic weakness. Which of the following genetic defects is most commonly associated with this condition?
---
- (A) SMN1 gene deletion
- (B) Mutations in SLC52A2 / SLC52A3 (riboflavin transporter genes)
- (C) Mutations in DMPK gene
- (D) Mutations in LMNA gene
💡 Click to Reveal Answer & Nelson Rationale
Option B (Mutations in SLC52A2 / SLC52A3 (riboflavin transporter genes))
Brown–Vialetto–Van Laere (BVVL) syndrome is a rare inherited neurodegenerative disorder that belongs to the group of riboflavin transporter deficiency disorders. It is caused by mutations in the SLC52A2 or SLC52A3 genes, which encode riboflavin transporters RFVT2 and RFVT3. Riboflavin (vitamin B2) is an essential precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), both of which are critical cofactors for mitochondrial enzymes involved in oxidative phosphorylation and energy metabolism. When riboflavin transport is impaired, cellular energy production is compromised, leading to progressive neuronal dysfunction and degeneration. Clinically it is a heterogeneous motor neuron disease that can present at any age and characteristically involves cranial nerves VII–XII with progressive facial weakness, dysphagia, tongue amyotrophy and fasciculations, bulbar palsy, sensorineural hearing loss, and respiratory insufficiency. Additional manifestations may include weakness of the arms and hands, optic atrophy, and ataxia. A closely related entity, Fazio–Londe syndrome, shares the progressive bulbar phenotype but lacks sensorineural deafness. Importantly, identifying the riboflavin transporter defect creates a targeted, disease-modifying therapy: high-dose riboflavin. Treatment is initiated at 10 mg/kg/day and titrated; in children doses may be increased up to 50 mg/kg/day, and in adults up to ~1500 mg/day, aiming for maximal clinical benefit. Responses range from rapid improvement to slower gains over ~12 months, stabilization, or rarely nonresponse. A useful clue is that BVVL can show abnormal acylcarnitine profiles mimicking multiple acyl-CoA dehydrogenase deficiency; these biochemical derangements typically improve on riboflavin, paralleling the clinical response.
Which of the following best describes the characteristic electromyographic (EMG) finding in Myasthenia Gravis (MG)?
---
- (A) Conduction block with markedly reduced nerve conduction velocity
- (B) Progressive increase in compound muscle action potential (CMAP) amplitude with repetitive stimulation
- (C) Decremental response in CMAP amplitude (>10%) with repetitive nerve stimulation
- (D) Spontaneous fibrillation potentials and positive sharp waves on needle EMG
💡 Click to Reveal Answer & Nelson Rationale
Option C (Decremental response in CMAP amplitude (>10%) with repetitive nerve stimulation)
The hallmark EMG finding in Myasthenia Gravis is a decremental CMAP response to low-frequency repetitive nerve stimulation (usually 2–3 Hz). During repetitive stimulation, the safety factor of neuromuscular transmission progressively decreases because of reduced acetylcholine receptor (AChR) availability at the postsynaptic membrane. As a result, end plate potentials fall below threshold, leading to failure of muscle fiber activation. This manifests electrophysiologically as a >10% reduction in CMAP amplitude between the 1st and 4th responses, a diagnostic criterion for neuromuscular transmission disorders. This decremental response correlates with the clinical fatigability seen in MG and is often reversible with cholinesterase inhibitors (e.g., pyridostigmine). Importantly, motor nerve conduction velocities remain normal, distinguishing MG from demyelinating neuropathies.
Which congenital myasthenic syndrome (CMS) subtype worsens with acetylcholinesterase inhibitors?
---
- (A) COLQ mutation (endplate acetylcholinesterase deficiency)
- (B) CHRNE mutation (AChR epsilon subunit)
- (C) CHAT mutation (choline acetyltransferase deficiency)
- (D) RAPSN mutation (receptor clustering defect)
💡 Click to Reveal Answer & Nelson Rationale
Option A (COLQ mutation (endplate acetylcholinesterase deficiency))
Congenital myasthenic syndromes (CMS) are a group of inherited disorders of the neuromuscular junction (NMJ) caused by genetic defects affecting presynaptic, synaptic, or postsynaptic proteins. Treatment responses vary depending on the subtype, making correct diagnosis essential. Acetylcholinesterase inhibitors (AChEIs), like pyridostigmine, are usually beneficial, but paradoxically, some CMS subtypes worsen with their use. In COLQ-related CMS, the anchoring protein for acetylcholinesterase (AChE) at the synaptic basal lamina is defective. This leads to absence or severe reduction of AChE at the NMJ. Consequently, acetylcholine persists in the synaptic cleft, causing prolonged depolarization, receptor desensitization, and ineffective neuromuscular transmission. Administering AChE inhibitors worsens the problem by further prolonging acetylcholine presence, making weakness more severe. These patients may instead benefit from adrenergic agonists like ephedrine or salbutamol. The clinical course is variable. Patients present in the neonatal period or in infancy with apnea and generalized weakness that persist through life. In some patients the ocular ductions are spared, and in some the pupillary light reflex is delayed. Milder cases associated with missense mutations in the C-terminal domain of ColQ may present later in childhood with limb-girdle weakness.
A 10-year-old child is evaluated for fatigue, mild proximal weakness, and persistently elevated serum creatine kinase. There is no Gower sign, calf hypertrophy, myotonia, rash, or family history of muscular dystrophy. The clinician considers endocrine causes of nonneuromuscular creatine kinase elevation. Which endocrine disorder is a recognized cause?
---
- (A) Hypothyroidism
- (B) Hyperthyroidism
- (C) Addison disease
- (D) Conn syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option A (Hypothyroidism)
Hypothyroidism is a recognized endocrine cause of elevated creatine kinase and may mimic primary muscle disease with fatigue, myalgia, cramps, or weakness. In a child with raised CK but no clear muscular dystrophy or inflammatory myopathy pattern, nonneuromuscular causes should be considered before proceeding to invasive investigations. Endocrine causes listed include hypothyroidism, rarely hyperthyroidism, hyperparathyroidism, acromegaly, and Cushing syndrome.
![[52f1aa86_1784800645683_1784800646.png]]
In neuromuscular disorders, cardiac assessment is important because several genetic disorders are associated with cardiomyopathy. All of the following are associated with dilated cardiomyopathy except:
---
- (A) Duchenne muscular dystrophy
- (B) Becker muscular dystrophy
- (C) Emery-Dreifuss muscular dystrophy
- (D) Friedreich ataxia
💡 Click to Reveal Answer & Nelson Rationale
Option D (Friedreich ataxia)
Dilated cardiomyopathy is associated with several neuromuscular disorders, including Duchenne muscular dystrophy, female carriers of Duchenne muscular dystrophy, Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy, limb-girdle muscular dystrophy, congenital muscular dystrophy, and limb-girdle muscular dystrophy 2I. Friedreich ataxia is the exception because it is classically associated with hypertrophic cardiomyopathy rather than dilated cardiomyopathy.
**Table:** Gene Variants and Cardiac Manifestations of the Neuromuscular Disorders
![[dcbe2378_large_table__17__1784890859.png]]
A newborn presents with severe hypotonia, poor feeding, respiratory distress, ptosis, and extraocular muscle weakness. Pregnancy was complicated by reduced fetal movements and polyhydramnios. Serum creatine kinase is normal. A congenital myopathy is suspected, and muscle biopsy is performed. Which biopsy finding is most characteristic of the likely diagnosis?
---
- (A) Numerous centrally placed nuclei in small muscle fibers
- (B) Nemaline rods within muscle fibers
- (C) Central cores with absent oxidative enzyme activity
- (D) Type 1 fibers smaller than type 2 fibers
💡 Click to Reveal Answer & Nelson Rationale
Option A (Numerous centrally placed nuclei in small muscle fibers)
The clinical picture is most consistent with myotubular myopathy/centronuclear myopathy. Among congenital myopathies, all may present with neonatal hypotonia and weakness, so this alone is not enough to differentiate them. The key differentiating clues here are severe neonatal presentation, facial weakness, ptosis, and especially extraocular muscle weakness. In the table, myotubular myopathy is the congenital myopathy in which neonatal hypotonia, severe neonatal disease, facial weakness, ptosis, and extraocular muscle weakness are all prominent. The characteristic biopsy finding is numerous centrally placed nuclei in small muscle fibers, reflecting the fetal myotube-like appearance of muscle fibers. Myotubular myopathy is not associated with cardiomyopathy (mature cardiac muscle fibers normally have central nuclei), but one report describes complete atrioventricular block without cardiomyopathy in a patient with confirmed X- linked myotubular myopathy. Congenital anomalies of the central nervous system (CNS) or of other systems are not associated.
**Table:** Specific Congenital Myopathies: Distinguishing Clinical Features
![[ff3d66e5_small_table__7__1784891730.png]]
A 14-year-old child with slowly progressive distal-predominant weakness and muscle wasting is diagnosed with a myofibrillar myopathy after muscle biopsy and molecular genetic testing. The family asks about possible disease-modifying treatments being explored in experimental models. Which of the following drugs is an antiaggregation agent mentioned in this context?
---
- (A) N-acetyl-L-cysteine
- (B) 4-phenylbutyrate
- (C) Rapamycin
- (D) Idebenone
💡 Click to Reveal Answer & Nelson Rationale
Option B (4-phenylbutyrate)
Myofibrillar myopathies are rare progressive neuromuscular disorders, also grouped as protein aggregate myopathies. They can present with variable skeletal muscle weakness, often distal or mixed distal-proximal, muscle wasting, respiratory involvement, and important cardiac disease such as cardiomyopathy or conduction abnormalities. Pathologically, they show focal disintegration of myofibrils beginning at the Z-disc, accumulation of myofibrillar degradation products, and abnormal protein aggregates. There is no curative treatment; care is supportive with cardiac surveillance, respiratory support, physiotherapy, assistive devices, and genetic counseling. In experimental models, possible strategies include avoiding strenuous exercise, antioxidant therapy with N-acetyl-L-cysteine, modulation of autophagy, and antiaggregation drugs such as doxycycline and 4-phenylbutyrate. 4-phenylbutyrate is also described as a chemical chaperone approved for urea cycle disorders.
A 4-year-old boy is diagnosed with Duchenne muscular dystrophy after blood-based DNA analysis identifies a pathogenic dystrophin gene variant. His mother is currently 11 weeks pregnant and asks about fetal testing in this pregnancy. The family also asks whether the boy’s sisters and female cousins can be tested for carrier status. Which statement is most accurate?
---
- (A) Use serum CK for carrier testing; prenatal diagnosis is reliable only after 20 weeks
- (B) Routine newborn screening makes carrier and prenatal testing unnecessary
- (C) Use blood DNA analysis for carrier testing; CVS can diagnose by 12 weeks
- (D) Use blood DNA analysis for carrier testing; amniocentesis is the earliest prenatal test
💡 Click to Reveal Answer & Nelson Rationale
Option C (Use blood DNA analysis for carrier testing; CVS can diagnose by 12 weeks)
Once the dystrophin gene variant has been identified in an affected child with DMD, the same DNA-based methods can be applied to blood samples from at-risk female relatives, including sisters and cousins, for carrier detection. Testing the mother is important because, despite X-linked recessive inheritance, approximately 30% of DMD cases result from a new or de novo pathogenic variant, and the mother is not always a carrier. Prenatal diagnosis is possible as early as the 12th week of gestation by chorionic villus sampling for DNA analysis using methods such as Southern blot or PCR. Female carriers are usually asymptomatic, but a small proportion may manifest weakness due to skewed X-inactivation, explained by the Lyon hypothesis. Rarely, the full DMD phenotype can occur in females with Turner syndrome if the single X chromosome carries the Xp21 deletion. Newborn screening for DMD is not currently part of routine neonatal screening, although a CK-based test may be available for families requesting screening.
A 12-year-old boy presents with acute severe myalgia, weakness, dark-colored urine, and markedly elevated serum CK after taking a drug for fever. Toxic myopathy with rhabdomyolysis and myoglobinuria is suspected. Which of the following drugs is classically listed under rhabdomyolysis and myoglobinuria?
---
- (A) Cimetidine
- (B) L-tryptophan
- (C) Statin
- (D) D-penicillamine
💡 Click to Reveal Answer & Nelson Rationale
Option C (Statin)
Toxic myopathies may be inflammatory, necrotizing/vacuolar, rhabdomyolytic, malignant hyperthermia–related, mitochondrial, or associated with myotonia or myosin loss. Statins are important because they are listed both under noninflammatory necrotizing or vacuolar toxic myopathy and under rhabdomyolysis with myoglobinuria. In a child with acute myalgia, weakness, dark urine, and markedly elevated CK, statin-associated rhabdomyolysis is the best answer among the options.
![[9f509684_large_table__27__1784906897.png]]
All of the following metals are recognized causes of toxic neuropathy except:
---
- (A) Arsenic
- (B) Lead
- (C) Gold
- (D) Cobalt
💡 Click to Reveal Answer & Nelson Rationale
Option D (Cobalt)
Toxic neuropathy can occur after exposure to several metals. The important metals listed as causes include arsenic, gold, lead, lithium, mercury, thallium, and zinc. Arsenic exposure may occur through insecticides and herbicides. Lead exposure may occur through paint, batteries, and pottery. Mercury exposure may be metallic or vaporized, thallium may be found in rodenticides, and zinc toxicity may occur with chronic excessive intake. Gold and lithium are also included among the recognized metal-related causes of toxic neuropathy.
![[0ca053d6_1784801325150_1784801325.png]]
Cobalt is a close distractor because it is a metal and can be associated with systemic toxicity in other contexts, but it is not included in this listed group of metals causing toxic neuropathy.
Which antiganglioside antibody is most classically associated with Miller Fisher syndrome?
---
- (A) Anti-GM1
- (B) Anti-GD1a
- (C) Anti-GQ1b
- (D) Anti-GD1b
💡 Click to Reveal Answer & Nelson Rationale
Option C (Anti-GQ1b)
Miller Fisher syndrome is a variant within the Guillain-Barré syndrome spectrum. The classic clinical triad is ophthalmoplegia, ataxia, and areflexia. The most characteristic antiganglioside antibody associated with Miller Fisher syndrome is anti-GQ1b. This antibody is also relevant in related ophthalmoplegia/brainstem variants, but for a direct Miller Fisher syndrome antibody question, anti-GQ1b is the key answer.
**Table: **Clinical Classification of Guillain Syndrome
![[3329bbf0_large_table__19__1784894184.png]]
A 4-year-old child presents with a history of developmental delay, facial weakness, and hypotonia since infancy. Examination reveals an elongated face, ptosis, and a downturned mouth appearance. His mother has difficulty releasing her grip after a handshake and a history of cataracts. Which of the following statements is NOT true regarding this condition?
---
- (A) Cardiac conduction defects are a known complication
- (B) Cognitive impairment may be seen
- (C) Myotonia can be seen in infancy
- (D) It is associated with CTG trinucleotide repeat expansion in the DMPK gene
💡 Click to Reveal Answer & Nelson Rationale
Option C (Myotonia can be seen in infancy)
Myotonic Dystrophy Type 1 (DM1) is a multisystem autosomal dominant disorder caused by a CTG trinucleotide repeat expansion in the DMPK gene on chromosome 19q13.3. The severity and age of onset depend on the number of repeats, with larger expansions leading to congenital or childhood-onset forms. In congenital and infantile forms, hypotonia (floppy baby), facial diplegia with downturned mouth, poor feeding, and developmental delay are often present from birth. However, myotonia (delayed muscle relaxation after contraction) is characteristically absent in infancy, both clinically and on electromyography (EMG). Maternal history of myotonia, cataracts, muscle cramps and clumsiness provides important clues. It becomes evident around 5 years of age.
A 12-year-old boy presents with progressive difficulty smiling, incomplete eye closure during sleep, and weakness in lifting his arms overhead. Parents report that he had normal milestones until age 8, when he began developing shoulder asymmetry and struggled to raise his arms. Examination reveals facial diplegia with inability to puff cheeks, scapular winging, and asymmetric weakness of the biceps and triceps. The deltoids are relatively spared. He walks independently and has no calf hypertrophy. Fundus examination is planned as part of systemic screening. His maternal uncle is known to have a similar illness. Which of the following findings is not typically associated with this condition?
---
- (A) Contraction of the D4Z4 repeat on chromosome 4q35
- (B) Coats-like exudative retinopathy
- (C) Progressive sensorineural hearing loss
- (D) Cardiomyopathy with early conduction defects
💡 Click to Reveal Answer & Nelson Rationale
Option D (Cardiomyopathy with early conduction defects)
The described presentation is classic for Facioscapulohumeral Muscular Dystrophy (FSHD), 3rd most common inherited muscular dystrophies, typically inherited in an autosomal dominant manner with genetic anticipation. FSHD is caused by a contraction of D4Z4 macrosatellite repeats on chromosome 4q35. This deletion leads to inappropriate expression of the DUX4 gene, which encodes a toxic transcription factor that interferes with normal muscle development and survival. FSHD mainly affects the facial muscles, scapular stabilizers, and upper arms (notably sparing the deltoid). Over time, it can involve abdominal and foot dorsiflexor muscles, leading to lumbar lordosis and foot drop. Cardiomyopathy with early conduction defects is NOT typical of FSHD. In contrast, Emery-Dreifuss muscular dystrophy and Duchenne muscular dystrophy often have significant cardiac involvement early in the course.
A 7-month-old infant with hypotonia and severe feeding difficulties is diagnosed with congenital myasthenic syndrome (CMS) due to a mutation in the COLQ gene. Which of the following statements is TRUE regarding this subtype?
---
- (A) It responds well to acetylcholinesterase inhibitors
- (B) It is caused by defective acetylcholine receptor function
- (C) The mutation leads to end-plate acetylcholinesterase deficiency
- (D) Repetitive nerve stimulation shows an incremental response
💡 Click to Reveal Answer & Nelson Rationale
Option C (The mutation leads to end-plate acetylcholinesterase deficiency)
Congenital myasthenic syndromes (CMS) are a group of inherited disorders of the neuromuscular junction (NMJ) caused by genetic defects affecting presynaptic, synaptic, or postsynaptic proteins. Treatment responses vary depending on the subtype, making correct diagnosis essential. Acetylcholinesterase inhibitors (AChEIs), like pyridostigmine, are usually beneficial, but paradoxically, some CMS subtypes worsen with their use. Mutations in the COLQ gene cause a synaptic CMS. In COLQ-related CMS, the anchoring protein for acetylcholinesterase (AChE) at the synaptic basal lamina is defective. This leads to absence or severe reduction of AChE at the NMJ. Consequently, acetylcholine persists in the synaptic cleft, causing prolonged depolarization, receptor desensitization, and ineffective neuromuscular transmission. Administering AChE inhibitors worsens the problem by further prolonging acetylcholine presence, making weakness more severe. These patients may instead benefit from adrenergic agonists like ephedrine or salbutamol. Clinically, infants present with generalized hypotonia, severe feeding difficulties, and apnea in the neonatal or infantile period. The course is variable: some patients have sparing of ocular motility or delayed pupillary reflexes; milder phenotypes may present later with limb-girdle weakness. Repetitive nerve stimulation usually shows a decremental response.
A 12-year-old boy presents with progressive distal weakness, areflexia, and pes cavus. Nerve conduction studies reveal markedly reduced motor conduction velocities and conduction block. Genetic testing reveals PMP22 gene duplication. Which of the following BEST describes the underlying pathology?
---
- (A) Demyelination due to PMP22 overexpression causing Schwann cell dysfunction
- (B) Axonal degeneration due to mitochondrial dysfunction
- (C) Immune-mediated attack on peripheral nerves
- (D) Deficiency of dystrophin in Schwann cells
💡 Click to Reveal Answer & Nelson Rationale
Option A (Demyelination due to PMP22 overexpression causing Schwann cell dysfunction)
Peripheral neuropathies can be broadly classified into demyelinating (affecting the myelin sheath) and axonal. Demyelinating neuropathies show markedly reduced nerve conduction velocities, while axonal neuropathies usually present with normal velocities and reduced amplitude. Charcot-Marie-Tooth diseases (CMTDs) are a group of hereditary motor and sensory neuropathies characterized by chronic distal muscle weakness, atrophy, and sensory loss. They are broadly classified into demyelinating types (CMT1, CMT3) and axonal types (CMT2) based on nerve conduction studies. Among the most common genetic causes of demyelinating CMT, the PMP22 gene (Peripheral Myelin Protein 22) plays a central role. Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited neuropathy, caused by duplication of the PMP22 gene. This leads to overexpression of PMP22 protein in Schwann cells, resulting in abnormal myelin folding, segmental demyelination, and onion bulb formation. Over time, there is secondary axonal degeneration, which contributes to progressive distal weakness, areflexia, and foot deformities like pes cavus. Nerve conduction studies typically reveal markedly reduced conduction velocities and sometimes conduction block, consistent with demyelination.
A 5-year-old child presents with delayed milestones and fatigable weakness. Muscle biopsy shows central cores on oxidative enzyme staining. Which gene mutation is most likely responsible, and what is the main pathophysiological defect?
---
- (A) RYR1 mutation causing abnormal calcium release from sarcoplasmic reticulum
- (B) DNM2 mutation causing impaired mitochondrial fission
- (C) COL6A1 mutation causing extracellular matrix defects
- (D) GMPPB mutation causing defective glycosylation
💡 Click to Reveal Answer & Nelson Rationale
Option A (RYR1 mutation causing abnormal calcium release from sarcoplasmic reticulum)
Congenital myopathies are a clinically and genetically heterogeneous group of inherited neuromuscular disorders that typically present in infancy or early childhood with hypotonia, generalized weakness, and delayed motor development. They are pathologically distinguished by specific structural abnormalities in skeletal muscle fibers, visible on histopathological examination, which form the basis of their classification. In contrast to muscular dystrophies, congenital myopathies are usually non-progressive or only slowly progressive, and serum creatine kinase (CK) levels are normal or only mildly elevated. Among these disorders, central core disease (CCD) represents one of the most frequent and best-characterized entities. It is named after the presence of “cores,” which are well-demarcated areas running along the length of muscle fibers that lack mitochondria and oxidative enzyme activity. These central cores are highlighted on oxidative stains such as NADH-tetrazolium reductase or succinate dehydrogenase. The majority of cases of CCD are caused by mutations in the RYR1 gene, which encodes the ryanodine receptor 1, a calcium-release channel located in the sarcoplasmic reticulum of skeletal muscle. This channel plays a crucial role in excitation-contraction coupling, a process by which depolarization of the muscle membrane is translated into calcium release from the sarcoplasmic reticulum, leading to muscle contraction. Mutations in RYR1 impair this mechanism in two principal ways: either by causing excessive calcium leak from the sarcoplasmic reticulum or by disrupting the ability of the channel to release calcium when triggered by depolarization. Both mechanisms result in defective excitation-contraction coupling, inefficient force generation, and clinical muscle weakness. On the histopathological level, these defects give rise to the characteristic central cores, which represent metabolically inactive regions of the fibre devoid of mitochondria and oxidative activity. Clinically, patients with CCD present with early hypotonia, motor developmental delay, proximal muscle weakness, and easy fatigability. Some may have skeletal deformities such as hip dislocation, scoliosis, or joint contractures. CK levels are usually normal or only mildly elevated, which helps differentiate CCD from dystrophinopathies or other muscular dystrophies. Importantly, RYR1 mutations also confer susceptibility to malignant hyperthermia, a life-threatening hypermetabolic reaction to certain anesthetics, making perioperative management a critical consideration. Therefore, the presence of delayed milestones and fatigable weakness in a child, coupled with muscle biopsy findings of central cores, points strongly to a diagnosis of central core disease due to RYR1 mutation, in which the fundamental defect lies in abnormal calcium release from the sarcoplasmic reticulum.
A neonate presents with severe hypotonia, poor suck, and absent spontaneous movements. Repetitive nerve stimulation shows a decremental response. Genetic testing reveals a mutation in the CHAT gene. Which of the following clinical features is most characteristic of this condition?
---
- (A) Episodic apnea with respiratory crises
- (B) Progressive limb-girdle muscle weakness in adolescence
- (C) Early contractures and scoliosis
- (D) Cognitive delay and brain malformations
💡 Click to Reveal Answer & Nelson Rationale
Option A (Episodic apnea with respiratory crises)
Endplate Choline Acetyltransferase (ChAT) deficiency is the most common presynaptic congenital myasthenic syndrome (CMS). ChAT is the key enzyme responsible for resynthesizing acetylcholine (ACh) by transferring an acetyl group from acetyl-CoA to choline in cholinergic neurons. Pathogenic mutations in ChAT impair enzyme expression, catalytic efficiency, or structural stability, leading to defective ACh resynthesis. During periods of high neuronal activity—such as exercise—the limited rate of ACh regeneration causes progressive depletion of vesicular ACh, resulting in reduced endplate potentials (EPPs) and compound muscle action potentials (CMAPs). Clinically, presentation is variable: some infants show hypotonia, bulbar weakness, and apnea at birth, while others appear normal initially but later develop recurrent apneic crises in infancy or childhood, often triggered by infection, excitement, or even without clear cause. These attacks may lead to prolonged respiratory insufficiency, and severe cases can cause ventilator dependence from birth, with risk of cerebral atrophy following hypoxemia. In milder phenotypes, patients may experience fatigable weakness, ptosis, ophthalmoparesis, or cyanotic episodes, often improving with age. Cold exposure exacerbates symptoms because it further reduces the catalytic efficiency of mutant ChAT. A useful diagnostic clue is prolonged recovery of CMAPs after repetitive nerve stimulation: whereas other CMS show recovery within 2–3 minutes, in ChAT deficiency, recovery is delayed to 5–15 minutes, making this a distinctive electrophysiological signature. Clinical features include: Severe neonatal hypotonia, poor suck, weak cry, and absent spontaneous movements Fatigable weakness that worsens with exertion Repetitive nerve stimulation (RNS): decremental response Episodic apnea and life-threatening respiratory crises, especially during intercurrent illness, are hallmark features Unlike acquired myasthenia gravis, CMS does not involve antibodies and does not respond to immunosuppressants Thus, episodic apnea with respiratory crises is the most characteristic clinical finding in CHAT-related CMS.
A 6-month-old infant is brought for evaluation of severe muscle weakness present since birth. Examination reveals generalized hypotonia, multiple proximal joint contractures (especially elbows and knees), distal joint hyperlaxity in hands and feet, and frequent respiratory infections requiring airway suctioning. The skin shows keratosis pilaris on the arms and legs. Muscle MRI shows a "central cloud" appearance in the rectus femoris. Which of the following gene mutations is most likely responsible for this condition?
---
- (A) COL6A2
- (B) SEPN1
- (C) RAPSN
- (D) DMD
💡 Click to Reveal Answer & Nelson Rationale
Option A (COL6A2)
Mutations in the COL6A1, COL6A2, and COL6A3 genes—which encode the three chains of collagen type VI, a vital extracellular matrix protein in muscle and connective tissue—cause collagen VI–related myopathies. These include Ullrich Congenital Muscular Dystrophy (Ullrich CMD) and Bethlem Myopathy. Ullrich CMD is characterized by: Severe congenital hypotonia and weakness from birth Proximal joint contractures (elbows, knees) combined with distal joint hyperlaxity (hands, feet) Respiratory insufficiency, often requiring airway suctioning or ventilatory support Skin changes, particularly keratosis pilaris on the arms and legs Muscle MRI finding of the “central cloud” sign in the rectus femoris, which is highly characteristic The unique combination of proximal stiffness, distal laxity, respiratory involvement, and skin findings points strongly toward a collagen VI–related myopathy.
![[8d221c84_small__54__1760169975.png]]
A 16-year-old boy with symptoms of muscle stiffness after exercise and tea-colored urine following strenuous activity is evaluated. Lab tests reveal raised serum creatine kinase and myoglobinuria. What is the most likely enzyme deficiency?
---
- (A) Myophosphorylase
- (B) Acid maltase
- (C) Carnitine palmitoyltransferase II
- (D) Pyruvate dehydrogenase
💡 Click to Reveal Answer & Nelson Rationale
Option A (Myophosphorylase)
McArdle disease, also known as glycogen storage disease type V, is a rare autosomal recessive disorder caused by mutations in the PMGM gene located on chromosome 11q13. The condition results from a deficiency of the enzyme muscle glycogen phosphorylase, which is crucial for breaking down glycogen into glucose-1-phosphate within skeletal muscle. Because of this enzymatic defect, affected individuals are unable to adequately mobilize glycogen during exercise, leading to impaired energy supply in muscle fibers. Clinically, patients often present during adolescence or early adulthood with exercise intolerance, muscle pain, cramps, and recurrent episodes of rhabdomyolysis, which can manifest as tea-colored urine due to myoglobinuria and persistently elevated serum creatine kinase. A distinctive clinical hallmark is the “second-wind phenomenon”, where symptoms improve after a few minutes of exercise as the muscle shifts to alternative energy sources, primarily through increased blood-borne glucose and free fatty acids. In this metabolic myopathy, there is impaired breakdown of glycogen to glucose-1-phosphate, compromises energy supply to muscles during anaerobic activity. As glycolysis is disrupted, pyruvate cannot be converted to lactate during exercise, leading to the diagnostic finding of absent lactate rise on the ischemic forearm exercise test. Clinically, patients develop exercise intolerance, muscle cramps, rhabdomyolysis with elevated serum CK, and myoglobinuria, although muscle strength and CK levels remain normal between episodes. Diagnosis can be established by histochemical or biochemical analysis of muscle biopsy demonstrating myophosphorylase deficiency, MR spectroscopy showing absent fall in intramuscular pH with excessive phosphocreatine depletion, and genetic testing confirming pathogenic variants in the PMGM gene.
A 9-year-old boy presents with a 5-day history of progressive weakness that began in the lower limbs and has ascended to involve the arms and face. He has difficulty swallowing with episodes of nasal regurgitation. Neurological examination reveals absent reflexes in all limbs. Nerve conduction studies demonstrate decreased conduction velocities, prolonged distal motor latencies, and abnormal F-waves consistent with demyelination. Cerebrospinal fluid (CSF) analysis shows elevated protein with a normal cell count. Which of the following statements about this patient’s condition is most accurate?
---
- (A) The classic electrophysiological pattern suggests acute motor axonal neuropathy (AMAN) subtype
- (B) Autonomic dysfunction is uncommon in pediatric GBS and does not influence prognosis
- (C) Early intravenous immunoglobulin (IVIG) therapy can reduce the risk of respiratory failure
- (D) Electromyography (EMG) is more sensitive than nerve conduction studies in detecting demyelination
💡 Click to Reveal Answer & Nelson Rationale
Option C (Early intravenous immunoglobulin (IVIG) therapy can reduce the risk of respiratory failure)
Guillain–Barré Syndrome (GBS) is the most common cause of acute flaccid paralysis in children worldwide. It is an acute immune-mediated polyradiculoneuropathy, usually triggered by a preceding infection (commonly Campylobacter jejuni, CMV, EBV, or Mycoplasma). The immune response causes demyelination and/or axonal injury of peripheral nerves, resulting in rapidly progressive weakness. The clinical vignette is typical of GBS in children, characterized by: Ascending weakness beginning in the lower limbs and progressing to involve arms, face, and bulbar muscles Areflexia on examination Demyelinating features on nerve conduction studies (slowed conduction velocities, prolonged distal latencies, abnormal F-waves) Albuminocytologic dissociation on CSF (elevated protein with normal cell count) Treatment with IVIG (2 g/kg over 2–5 days) or plasma exchange is recommended in children with GBS who have significant weakness or rapid progression. Early initiation of therapy has been shown to shorten time to recovery, reduce severity, and decrease complications such as respiratory failure and prolonged mechanical ventilation. Thus, early IVIG improves prognosis and is the mainstay of therapy in pediatric GBS.
A 4-month-old infant presents with severe hypotonia, developmental delay, and poor motor milestones. Laboratory reports show a creatine kinase (CK) level of 2500 IU/L. Brain MRI reveals hydrocephalus, pachygyria, and white matter changes. On examination, there is profound muscle weakness, and parents report delayed head control. Which genetic subtype of congenital muscular dystrophy is most likely responsible for this clinical presentation?
---
- (A) Alpha-dystroglycanopathy
- (B) LMNA-related congenital muscular dystrophy
- (C) LAMA2-related congenital muscular dystrophy
- (D) Collagen VI-related congenital muscular dystrophy
💡 Click to Reveal Answer & Nelson Rationale
Option A (Alpha-dystroglycanopathy)
Congenital muscular dystrophies (CMDs) are a heterogeneous group of hereditary muscle diseases that begin in the prenatal, neonatal, or early-infantile period and show histologic features of a dystrophic process. They are characterized by diffuse hypotonia, weakness, thin muscle mass, poor head control due to axial weakness, and often distal arthrogryposis, though sucking and swallowing are usually preserved. Unlike other muscular dystrophies, CMDs are highly associated with central nervous system malformations such as lissencephaly, pachygyria, polymicrogyria, cerebellar hypoplasia, and white matter changes, sometimes leading to severe epilepsy and developmental delay. The serum CK is moderately to markedly elevated (hundreds to several thousand IU/L), and EMG shows nonspecific myopathic features. Among the CMDs, a major group is caused by defective glycosylation of α-dystroglycan (α-dystroglycanopathies), which include Walker-Warburg syndrome, Fukuyama CMD, and muscle-eye-brain disease. These disorders result from variants in genes such as POMT1, POMT2, POMGnT1, FKTN, FKRP, etc. The pathogenesis involves defective glycosylation of dystroglycan, disrupting its role in linking the muscle sarcolemma with the extracellular matrix and basal lamina, as well as impairing the integrity of the glia limitans in the brain. This results in abnormal neuroblast migration and cobblestone lissencephaly, pachygyria, glioneuronal heterotopia, and hydrocephalus, along with variable eye abnormalities such as myopia or retinal hypoplasia. Cardiac involvement, including dilated cardiomyopathy, can be seen with certain mutations like FKRP and FKTN. The given case describes an infant with: Severe hypotonia and developmental delay from early infancy Markedly elevated creatine kinase (CK) (~2500 IU/L, supportive of a dystrophic process) Brain MRI abnormalities: hydrocephalus, pachygyria (cortical malformation), and white matter changes Profound muscle weakness with delayed head control These features strongly suggest an alpha-dystroglycanopathy, a group of CMDs caused by defective glycosylation of α-dystroglycan, a protein critical for linking the extracellular matrix to the dystrophin-glycoprotein complex. Alpha-dystroglycanopathies include severe forms such as: Walker–Warburg syndrome (most severe, with lissencephaly, hydrocephalus, ocular malformations) Muscle–Eye–Brain disease Fukuyama congenital muscular dystrophy The hallmark is the combination of congenital muscular dystrophy, structural brain malformations (pachygyria, hydrocephalus), and sometimes ocular abnormalities, which aligns with this clinical vignette.
A 7-year-old child is evaluated for progressive weakness. He has difficulty climbing stairs and rising from the floor. Examination shows marked weakness and hypotonia. Deep tendon reflexes are reduced, but sensation is normal. There are visible tongue fasciculations and mild muscle wasting. Serum creatine kinase is only moderately elevated. There is no diurnal fluctuation, ptosis, diplopia, sensory loss, or bladder involvement. Which site of lesion best explains this pattern?
---
- (A) Peripheral nerve
- (B) Neuromuscular junction
- (C) Anterior horn cell / alpha motor neuron
- (D) Muscle
💡 Click to Reveal Answer & Nelson Rationale
Option C (Anterior horn cell / alpha motor neuron)
This is a localization question. Marked weakness with hypotonia and reduced reflexes initially suggests a lower motor unit disorder, but the key discriminators are fasciculations, preserved sensation, and only normal to moderately elevated creatine kinase. Fasciculations strongly point toward anterior horn cell or alpha motor neuron involvement, as seen in spinal muscular atrophy and related disorders. Sensation remains normal because the primary lesion affects motor neurons rather than peripheral sensory nerves. Creatine kinase may be normal to moderately elevated but is usually not as markedly elevated as in primary muscle disease. The absence of fluctuating fatigability makes neuromuscular junction disease unlikely.
**Table: **Localization of Symptoms on Neural Axis
![[7469459c_large_table__20__1784894522.png]]
![[983e2d5c_1784801690311_1784801690.png]]
A 5-year-old child develops acute flaccid weakness 4 days after a febrile illness. He remains alert and has no sensory level or bladder dysfunction. Examination shows markedly reduced tone and reflexes in the affected limbs, with relatively preserved sensation. Which pattern of weakness is most characteristic of the likely diagnosis?
---
- (A) Symmetric ascending weakness, legs more than arms
- (B) Asymmetric weakness, arms more than legs
- (C) Symmetric ascending weakness, arms more than legs
- (D) Asymmetric weakness, legs more than arms
💡 Click to Reveal Answer & Nelson Rationale
Option B (Asymmetric weakness, arms more than legs)
The clinical picture is most consistent with acute flaccid myelitis. The key clues are acute onset after a febrile prodrome, flaccid weakness, reduced tone and reflexes, preserved mental status, and relatively preserved sensation. AFM predominantly affects the spinal cord gray matter, especially the anterior horn cell region, producing a poliomyelitis-like lower motor neuron syndrome. The weakness is typically asymmetric and often affects the upper limbs more than the lower limbs. Absence of a sensory level and bladder dysfunction helps separate AFM from transverse myelitis, while the asymmetry and arm predominance help separate it from Guillain-Barré syndrome.
**Table: **Differentiating Acute Flaccid Myelitis from Mimics
![[de1f215d_medium_table__19__1784896562.png]]
**Table: **Differentiating Acute Flaccis Myelities from Clinical Mimics–cont'd
![[5559a837_large_table__22__1784896746.png]]
A hypotonic infant is diagnosed on muscle biopsy with congenital muscle fiber–type disproportion. The clinician explains to the parents that this finding should not always be considered a single isolated myopathy, because it may occur in association with several unrelated disorders. Which of the following associated conditions is classically described with this syndrome?
---
- (A) Krabbe disease
- (B) Wilson disease
- (C) Tay-Sachs disease
- (D) Lesch-Nyhan syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option A (Krabbe disease)
Congenital muscle fiber–type disproportion may occur as an isolated congenital myopathy, but it can also develop in association with several unrelated disorders; therefore, it is best regarded as a syndrome rather than a single disease entity. As an isolated disorder, CMFTD is usually present at birth and is nonprogressive or only slowly progressive. Infants have generalized hypotonia and weakness, poor head control, delayed gross motor milestones, reduced muscle bulk, dolichocephaly, facial weakness, and a high-arched palate. The hypotonia and wasting may appear greater than the actual weakness, so the child may seem stronger than expected during examination. CK, ECG, EMG, and nerve conduction studies are usually normal in isolated CMFTD. Biopsy shows uniformly small type I fibers, hypertrophic type II fibers, and type I fibers more numerous than type II fibers, without degeneration or primary myopathic changes. Associated conditions include nemaline rod disease, Krabbe disease or globoid cell leukodystrophy early in the course before neuropathy becomes evident, merosin-deficient congenital muscular dystrophy, cerebellar hypoplasia and other brain malformations, fetal alcohol syndrome, some glycogenoses, multiple sulfatase deficiency, Lowe syndrome, rigid spine myopathy, and some infantile cases of myotonic muscular dystrophy.
A 6-year-old child has progressive asymmetric enlargement of one lower limb, verrucous cutaneous lesions, patchy angiomatous malformations, thickened bones, and excessive growth of muscles without true weakness. MRI brain shows hemimegalencephaly. Genetic testing from affected tissue reveals a postzygotic mosaic variant involving the mTOR pathway. Which gene is most likely involved?
---
- (A) AKT1
- (B) AKT3
- (C) PTEN
- (D) PIK3CA
💡 Click to Reveal Answer & Nelson Rationale
Option A (AKT1)
This child has Proteus syndrome, a disorder of cellular overgrowth involving ectodermal and mesodermal tissues due to postzygotic somatic mosaicism. The genetic defect is a mosaic variant in AKT1, a gene in the same pathway family as AKT3. These genes participate in the mammalian target of rapamycin, or mTOR, pathway. Proteus syndrome causes asymmetric overgrowth of the extremities, verrucous cutaneous lesions, angiomas, thickening of bones, and excessive muscle growth without weakness. Hemimegalencephaly may occur in Proteus syndrome as another tissue overgrowth manifestation, not as a separate unrelated association.
A newborn has congenital contractures predominantly involving the hands and feet. The proximal joints are largely spared. Examination shows camptodactyly, hypoplastic flexion creases, overriding fingers, ulnar deviation at the wrists, and bilateral talipes equinovarus. There is no evidence of a primary neurologic or muscle disease affecting limb function. Which term best describes this pattern?
---
- (A) Arthrogryposis multiplex congenita
- (B) Amyoplasia
- (C) Distal arthrogryposis
- (D) Benign congenital hypotonia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Distal arthrogryposis)
Distal arthrogryposis is a subtype of arthrogryposis in which congenital contractures mainly involve the distal parts of the limbs, especially the hands and feet, while the proximal joints are largely spared. Typical diagnostic features include camptodactyly or pseudocamptodactyly, hypoplastic or absent flexion creases, overriding fingers, ulnar deviation at the wrist, talipes equinovarus, calcaneovalgus deformities, vertical talus, and metatarsus varus. An important defining feature is that there is no primary neurologic or muscle disease affecting limb function.
Arthrogryposis itself is a sign rather than a diagnosis. It results from anything that interferes with or limits normal fetal movement, leading to congenital contractures. These contractures usually involve the limbs, but may also involve the jaw, neck, and spine. They are typically nonprogressive and may improve over time with early physiotherapy and orthopedic interventions. Amyoplasia and distal arthrogryposis are the two most common categories, together accounting for approximately 50–65% of patients presenting with arthrogryposis.
**Table: Consensus-Based Definitions****
![[68ebd518_small_table__8__1784897439.png]]
**
A 9-year-old child has recurrent episodes of flaccid weakness. Attacks occur after rest following exercise or after oral glucose intake. Examination between attacks shows short stature and dysmorphic features. ECG during evaluation shows prolonged QT interval with ventricular dysrhythmia. There is no myotonia. Which channelopathy is most likely?
---
- (A) Calcium channel hypokalemic periodic paralysis
- (B) Sodium channel hypokalemic periodic paralysis
- (C) Andersen syndrome
- (D) Thyrotoxic periodic paralysis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Andersen syndrome)
This clinical pattern is most consistent with Andersen syndrome, also called periodic paralysis with cardiac dysrhythmia. It is a dominantly inherited channelopathy presenting in the first or second decade with episodic weakness, often provoked by rest after exercise or oral glucose. The distinguishing clues are the associated systemic and cardiac features: short stature, dysmorphic features, prolonged QT interval, and ventricular dysrhythmias. Myotonia is absent. These cardiac features separate Andersen syndrome from the more typical calcium or sodium channel hypokalemic periodic paralyses.
**Table: **Channelopathies with Hypokalemic Periodic Paralysis
![[c67805b0_large_table__29__1785000079.png]]
A 17-year-old adolescent with severe generalized myasthenia gravis remains symptomatic despite standard therapy. He is acetylcholine receptor antibody–positive. The treating team discusses a newer agent, efgartigimod. Which mechanism best describes this drug?
---
- (A) Depletion of CD20-positive B cells
- (B) Blockade of neonatal Fc receptor–mediated IgG recycling
- (C) Inhibition of terminal complement C5 activation
- (D) Blockade of IL-6 receptor–mediated B-cell activation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Blockade of neonatal Fc receptor–mediated IgG recycling)
Efgartigimod is an antibody fragment that acts as a neonatal Fc receptor antagonist. The neonatal Fc receptor normally protects IgG from degradation by recycling it back into the circulation. Blocking this receptor increases IgG breakdown and lowers circulating pathogenic IgG, including acetylcholine receptor antibodies in generalized myasthenia gravis. It is FDA approved for patients aged 18 years or older with severe generalized AChR antibody–positive MG, with pediatric trials underway in children 2–18 years of age.
A 12-year-old child with juvenile myasthenia gravis develops a respiratory infection. The physician wants to avoid antibiotics that may worsen neuromuscular transmission and precipitate increased weakness. Which antibiotic should be avoided?
---
- (A) Amoxicillin
- (B) Azithromycin
- (C) Levofloxacin
- (D) Linezolid
💡 Click to Reveal Answer & Nelson Rationale
Option C (Levofloxacin)
Children with myasthenia gravis are vulnerable to drugs that impair neuromuscular transmission. Certain antibiotics can potentiate myasthenia and should be avoided whenever possible, especially aminoglycosides and fluoroquinolones. Levofloxacin is a fluoroquinolone and can worsen myasthenic weakness, making it the best answer. Other drugs that may exacerbate myasthenia include β-blocking agents, procainamide, and chloroquine. Children with MG also poorly tolerate neuromuscular-blocking drugs such as succinylcholine and pancuronium and may remain paralyzed for prolonged periods after even a single dose; therefore, any surgical anesthetic should be planned and administered by an experienced anesthesiologist.
A 2-month-old infant has severe hypotonia, poor feeding, and respiratory distress. Pregnancy was complicated by reduced fetal movements and polyhydramnios. Examination shows symmetric weakness, lower limbs more than upper limbs, absent deep tendon reflexes, tongue fasciculations, bell-shaped chest, and paradoxical abdominal breathing. Extraocular movements are preserved, and the infant appears alert. Which diagnosis is most likely?
---
- (A) Werdnig-Hoffmann disease
- (B) Congenital muscular dystrophy
- (C) Duchenne muscular dystrophy
- (D) Kugelberg-Welander disease
💡 Click to Reveal Answer & Nelson Rationale
Option A (Werdnig-Hoffmann disease)
This infant has spinal muscular atrophy type I, also called Werdnig-Hoffmann disease. SMA type I is the classic severe infantile phenotype and usually presents before 6 months of age with severe hypotonia, poor head control, little spontaneous movement, and symmetric generalized weakness. The weakness typically affects the lower limbs more than the upper limbs and proximal muscles more than distal muscles. Frog-leg posture, absent deep tendon reflexes, and tongue fasciculations are important lower motor neuron clues. Selective involvement of axial and intercostal muscles with relative diaphragmatic sparing produces weak cough, bell-shaped chest, and paradoxical abdominal breathing. Despite severe floppiness, infants often have an alert, bright expression with preserved cognition; facial and extraocular muscles are usually spared at presentation. Respiratory and swallowing difficulties are common, and respiratory failure usually develops within the first 2 years without adequate respiratory and nutritional support.
A 4-month-old infant with SMA type I is planned for treatment with onasemnogene abeparvovec-xioi. The parents are counselled that this single-dose therapy can markedly alter the natural history of SMA type I, but requires steroid cover and monitoring during the first month after treatment. Which adverse effect is specifically anticipated and explains the need for prednisolone?
---
- (A) Asymptomatic thrombocytopenia with moderate transaminase elevation
- (B) Immune-mediated hepatitis with ALT and AST elevation
- (C) Lumbar puncture–related headache with transient proteinuria
- (D) Oral ulceration with fever, diarrhea, and rash
💡 Click to Reveal Answer & Nelson Rationale
Option B (Immune-mediated hepatitis with ALT and AST elevation)
Onasemnogene abeparvovec-xioi is a single-dose intravenous gene replacement therapy for SMA. It uses an AAV9 vector to deliver a functional copy of SMN1, thereby increasing production of full-length SMN protein. It is mainly used for very young children with SMA type I. ALT and AST elevation may occur in the first month after treatment due to immune-mediated hepatitis; therefore, prednisolone is started the day before treatment and tapered over approximately 3–4 months. Rare but serious thrombotic microangiopathy can also occur. This therapy has substantially changed the natural history of SMA type I by improving survival, reducing need for permanent ventilation, and allowing acquisition or maintenance of motor milestones.
**Table: ** US Food and Drug Administration Approved SMA Therapeutics
![[fd3a8042_medium_table__23__1785000215.png]]
A 6-year-old child has intermittent distal paresthesias, gait imbalance, and weakness. Parents report progressive difficulty seeing in dim light and worsening hearing. He has ichthyosis, pes cavus, mild hepatomegaly, and reduced vibration sense. ECG shows conduction abnormality, and CSF protein is markedly elevated without pleocytosis. His diet includes frequent intake of foods rich in branched-chain fatty acids, including spinach, nuts, and coffee-containing products. Which gene pair is most classically implicated in this disorder?
---
- (A) PHYH and PEX7
- (B) ARSA and GALC
- (C) ABCD1 and PEX1
- (D) PMP22 and MPZ
💡 Click to Reveal Answer & Nelson Rationale
Option A (PHYH and PEX7)
The clinical picture is most consistent with classic Refsum disease, a rare autosomal recessive disorder of phytanic acid metabolism. The important clues are childhood onset with intermittent motor and sensory neuropathy, ataxia, night blindness due to retinitis pigmentosa, progressive sensorineural hearing loss, ichthyosis, skeletal deformities such as pes cavus, hepatomegaly or liver dysfunction, and cardiac involvement such as conduction disturbance or cardiomyopathy. CSF may show albuminocytologic dissociation, with markedly elevated protein but no pleocytosis, and nerve conduction studies show delayed motor and sensory conduction velocities. Refsum disease results from defective metabolism of phytanic acid, a branched-chain fatty acid obtained mainly from dietary sources such as spinach, nuts, and coffee-containing products. In classic Refsum disease, the classically implicated genes are PHYH at 10p13 and PEX7 at 6q22–q24. The infantile form is different from classic Refsum disease and may be caused by PEX1, PEX2, or PEX26 variants; it has additional clinical and biochemical features such as minor facial dysmorphism, retinitis pigmentosa, sensorineural hearing loss, hypercholesterolemia, hepatomegaly, and failure to thrive. The usual age of onset of classic Refsum disease is 4–7 years, often beginning with intermittent motor and sensory neuropathy. Recognition is important because treatment with dietary restriction of phytanic acid and periodic plasma exchange can improve outcomes, and life expectancy may be normal with careful management.
Roussy-Lévy syndrome is characterized by all of the following except:
---
- (A) Motor and sensory neuropathy type II
- (B) Cerebellar deficit
- (C) Pes cavus
- (D) Cardiomyopathy
💡 Click to Reveal Answer & Nelson Rationale
Option D (Cardiomyopathy)
Roussy-Lévy syndrome is defined by the combination of hereditary motor and sensory neuropathy type II with cerebellar deficit resembling Friedreich ataxia. Peripheral neuropathy features such as distal weakness, sensory loss, areflexia, and pes cavus may be present. The key differentiating point is that cardiomyopathy is not a feature of Roussy-Lévy syndrome.
A child with demyelinating hereditary motor and sensory neuropathy has distal weakness, pes cavus, distal sensory loss, and reduced nerve conduction velocity. He also has progressive macular degeneration and cutis laxa. Which type of Charcot-Marie-Tooth disease is most likely?
---
- (A) CMT1A
- (B) CMT1B
- (C) CMT1D
- (D) CMT1 plus
💡 Click to Reveal Answer & Nelson Rationale
Option D (CMT1 plus)
The combination of demyelinating hereditary motor and sensory neuropathy with macular degeneration and cutis laxa points to CMT1 plus. In the table, CMT1 plus is associated with FBLN5. This distinguishes it from the more common CMT1 subtypes, which present mainly with inherited demyelinating neuropathy without this characteristic eye and skin involvement.
**Table:** Nonsyndromic Inherited Neuropathies
![[b71f4291_medium_table__24__1785000352.png]]
A 19-year-old has recurrent painless injuries over the feet and tongue. Examination shows absent ankle reflexes, impaired distal proprioception and light touch, reduced sensitivity to painful heat, loss of corneal reflex with recurrent corneal abrasions, and early Charcot joint changes. He also has pupillary abnormalities, deafness, restless legs, and frequent muscle cramps. Family history suggests autosomal dominant inheritance. Which gene/pathway is most classically affected?
---
- (A) SCN9A sodium channel–mediated pain signaling
- (B) NTRK1 nerve growth factor receptor pathway
- (C) SPTLC1 serine palmitoyltransferase pathway in sphingolipid synthesis
- (D) WNK1/HSN2 sensory neuropathy pathway
💡 Click to Reveal Answer & Nelson Rationale
Option C (SPTLC1 serine palmitoyltransferase pathway in sphingolipid synthesis)
This clinical picture is most consistent with hereditary sensory and autonomic neuropathy type I (HSAN-I). The strongest clues are late-adolescent or young-adult onset, autosomal dominant inheritance, painless injuries over the feet and tongue, Charcot joint changes, loss of corneal reflex with recurrent corneal abrasions, deafness, pupillary abnormalities, restless legs, cramps, and absent reflexes. HSAN-I is the most common HSAN and affects all nerve fiber types, so the sensory deficit is not limited only to pain. Patients can have loss of proprioception, light touch, and sensitivity to noxious thermal stimuli.
The most classical molecular association is SPTLC1, which causes reduced activity of serine palmitoyltransferase, a key enzyme involved in sphingolipid synthesis. Sphingolipids are important components of neuronal membranes, so abnormal sphingolipid metabolism leads to membrane dysfunction and impaired signal transduction in sensory neurons. Therefore, the pain and temperature loss in HSAN-I is not primarily due to a receptor defect or sodium-channel pain pathway defect; it is related to disturbed membrane biology affecting peripheral nerve signaling. Other reported HSAN-I genes include SPTLC2, ATL1, ATL3, and DNMT1, but SPTLC1 remains the classic high-yield association.
Painless ulcers and tongue injuries occur because the patient does not adequately perceive painful trauma. Corneal abrasions occur because loss of corneal reflex reduces protective blinking and awareness of ocular irritation. Charcot joints develop due to repeated unperceived joint trauma, producing destructive arthropathy. Recurrent painless injuries may become complicated by osteomyelitis and sepsis.
An infant has recurrent unexplained fevers, severe feeding difficulty, poor tearing while crying, postural hypotension, and episodes of excessive sweating. Examination shows diminished reflexes, diffuse thermal insensitivity, and poor response to painful stimuli. Which type of hereditary sensory and autonomic neuropathy is most likely?
---
- (A) HSAN-I
- (B) HSAN-II
- (C) HSAN-III
- (D) HSAN-IV
💡 Click to Reveal Answer & Nelson Rationale
Option C (HSAN-III)
This infant has the classic phenotype of HSAN-III, also called Riley-Day syndrome or familial dysautonomia. It is usually identified in infancy and presents with prominent autonomic dysfunction. The major clues are defective tears, recurrent fevers, significant feeding problems, postural hypotension, hyperhidrosis, diminished or absent reflexes, poor detection of noxious stimuli, and diffuse thermal insensitivity. HSAN-III affects both unmyelinated fibers and large myelinated fibers, explaining the mixed autonomic and sensory manifestations.
HSAN-III is an autosomal recessive neurodevelopmental genetic disorder caused by variants in IKBKAP/ELP1 on chromosome 9q31.3. ELP1 encodes elongator complex protein 1, a scaffold protein involved in transcription of key neural proteins and regulation of kinases related to proinflammatory signaling. Pathology involves myelinated nerve terminals, dorsal root ganglia, spinal cord lateral root entry zones, Lissauer tracts, and parasympathetic afferents.
A 13-year-old receiving prolonged antibiotic therapy develops painful distal paresthesias and burning pain in the feet. Examination shows a predominantly sensory axonal neuropathy. Which of the following antibiotics is most classically associated with dose-dependent toxic neuropathy, especially after prolonged therapy, and may also cause optic neuropathy?
---
- (A) Nitrofurantoin
- (B) Linezolid
- (C) Vancomycin
- (D) Ciprofloxacin
💡 Click to Reveal Answer & Nelson Rationale
Option B (Linezolid)
Linezolid is classically associated with dose-dependent toxic peripheral neuropathy, mainly after prolonged courses. The typical neuropathy pattern is painful, predominantly sensory, and axonal, presenting with distal paresthesias, burning pain, and sensory symptoms. A key additional high-yield feature is that linezolid may also cause optic neuropathy, particularly with longer duration of therapy.
A 9-year-old child receiving chemotherapy for acute lymphoblastic leukemia develops distal weakness, constipation, and sensory symptoms in the feet. Examination shows reduced ankle reflexes and distal sensory loss. Which chemotherapy drug is most classically associated with this pattern of neuropathy?
---
- (A) Cisplatin
- (B) Paclitaxel
- (C) Vincristine
- (D) Bortezomib
💡 Click to Reveal Answer & Nelson Rationale
Option C (Vincristine)
The clinical picture is most consistent with vincristine-induced peripheral neuropathy, a high-yield chemotherapy-related neuropathy in pediatrics. Vincristine is a vinca alkaloid and typically causes distal weakness with sensory symptoms. Autonomic involvement is common, so constipation, ileus, urinary symptoms, or other autonomic features may occur. This makes vincristine especially important in children receiving chemotherapy for acute lymphoblastic leukemia.
**Table:** Chemotherapy Drugs Commonly Associated with Peripheral Neuropathy
![[94bbc316_large_table__30__1785000449.png]]
A 12-year-old child with suspected autonomic dysfunction is evaluated in the autonomic laboratory. The clinician wants to assess sympathetic cholinergic function. Which of the following tests is most appropriate?
---
- (A) Heart rate variability with deep respiration
- (B) Blood pressure response to upright posture
- (C) Quantitative sudomotor axon reflex test
- (D) Heart rate response to the Valsalva maneuver
💡 Click to Reveal Answer & Nelson Rationale
Option C (Quantitative sudomotor axon reflex test)
The quantitative sudomotor axon reflex test assesses sympathetic cholinergic function, specifically sudomotor or sweating pathways. Sympathetic cholinergic testing also includes thermoregulatory sweat testing, sweat imprint methods, and sympathetic skin response. These tests are useful when autonomic dysfunction presents with sweating abnormalities, heat intolerance, or suspected small-fiber autonomic involvement.
![[d3e8d93a_1784804239312_1784804239.png]]
A 9-year-old boy was treated 6 weeks ago for a presumed postinfectious acute flaccid paralysis after developing distal paresthesias and difficulty walking. He received IVIG and improved enough to walk with support. He now returns with gradually worsening difficulty rising from the floor, reduced grip strength, and recurrent tingling in the feet. His parents mention that he has had “good and bad weeks” rather than a single steady recovery. Examination shows mild symmetric weakness at the shoulders, hips, hands, and ankles with generalized areflexia. There is no ophthalmoplegia, facial diplegia, bladder involvement, marked tachycardia, blood pressure fluctuation, or altered sensorium. CSF shows elevated protein without pleocytosis. Nerve conduction study shows patchy demyelinating slowing. Which treatment strategy is most appropriate now?
---
- (A) Repeat IVIG alone
- (B) Start corticosteroids
- (C) Either repeat IVIG or start corticosteroids
- (D) Neither IVIG nor corticosteroids; only supportive care is indicated
💡 Click to Reveal Answer & Nelson Rationale
Option C (Either repeat IVIG or start corticosteroids)
This is a deliberately subtle GBS versus acute-onset CIDP scenario. The child initially looks like Guillain-Barré syndrome because there is a preceding infection, acute walking difficulty, paresthesias, areflexia, albuminocytologic dissociation, and partial improvement after IVIG. However, the later course is the key clue. He has renewed worsening and fluctuating weakness several weeks after treatment, with symptoms extending beyond the usual monophasic GBS course. CIDP should be suspected when weakness or paresthesias progress for more than 4–6 weeks, recur intermittently, or evolve over months.
CIDP usually causes both proximal and distal weakness with generalized hyporeflexia or areflexia. Sensory paresthesias are common, while cranial nerve and autonomic involvement are uncommon. CSF typically shows elevated protein without pleocytosis, and nerve conduction studies show demyelinating features with variable slowing. When biopsy is required, sural nerve biopsy may show patchy myelin loss and focal inflammatory changes. Acute-onset CIDP may be difficult to distinguish from GBS and from GBS with treatment-related fluctuations, so the time course is the most important discriminator.
Treatment differs once CIDP is suspected. In GBS, treatment is with IVIG, commonly 0.4 g/kg/day for 5 days or 1 g/kg/day for 2 days; plasmapheresis or immunosuppressive drugs may be alternatives if IVIG is ineffective. Steroids are not effective for GBS weakness, although they may help pain. Supportive care remains essential in GBS, including respiratory support, pressure sore prevention, constipation prevention, nutrition, pain control, DVT prevention, and treatment of secondary infections. Neuropathic pain should be treated aggressively, including agents such as gabapentin when needed.
In contrast, CIDP can be treated with either IVIG or oral/pulsed corticosteroids. Refractory cases may need other immunosuppressive medications. Children with relapsing or slowly progressive weakness often require treatment for months to years, but most eventually achieve sustained remission. Therefore, either repeat/maintenance IVIG or starting corticosteroids is appropriate in this child.
A child is being evaluated for suspected Guillain-Barré syndrome after developing progressive limb weakness and reduced tendon reflexes. Which finding would most strongly raise doubt about the diagnosis?
---
- (A) Mild distal paresthesias
- (B) Bilateral facial weakness
- (C) CSF polymorphonuclear cells 60/µL
- (D) Transient urinary retention during severe weakness
💡 Click to Reveal Answer & Nelson Rationale
Option C (CSF polymorphonuclear cells 60/µL)
In Guillain-Barré syndrome, CSF typically shows albuminocytologic dissociation, meaning elevated protein with no or minimal pleocytosis. A CSF mononuclear or polymorphonuclear cell count >50 cells/µL should strongly raise doubt about GBS and should prompt evaluation for alternative diagnoses such as infectious polyradiculitis, myelitis, spinal cord disease, or other inflammatory disorders.
Mild sensory symptoms such as distal paresthesias may occur in GBS. Bilateral facial weakness can also occur and is a supportive cranial nerve feature. Bladder or bowel dysfunction is a red flag when it is present at onset or is persistent, but transient urinary symptoms during severe weakness are less specific. Therefore, the most objective and strongest red flag here is CSF polymorphonuclear cells 60/µL.
![[7f6bf216_1784804489896_1784804490.png]]
A 10-year-old child develops acute unsteadiness, diplopia, and drowsiness after a recent respiratory illness. Examination shows ataxia, ophthalmoplegia, and impaired consciousness. Limb weakness is absent, sensory symptoms are minimal, and reflexes are reduced. Nerve conduction studies show an axonal pattern. Serum testing shows antiganglioside antibodies against GQ1b and GT1a. Which clinical variant within the Guillain-Barré syndrome spectrum is most likely?
---
- (A) Miller Fisher syndrome
- (B) Acute ophthalmoplegia
- (C) Bickerstaff brainstem encephalitis
- (D) Pharyngeal-cervical-brachial variant
💡 Click to Reveal Answer & Nelson Rationale
Option C (Bickerstaff brainstem encephalitis)
This child has Bickerstaff brainstem encephalitis, a rare disorder within the Guillain-Barré syndrome/Miller Fisher spectrum. The key differentiating clue is CNS involvement, shown here by drowsiness or impaired consciousness. Bickerstaff brainstem encephalitis classically presents with ophthalmoplegia, ataxia, and altered sensorium. It may have little or no limb weakness. Nerve conduction may show an axonal pattern, and antiganglioside antibodies commonly include GQ1b and GT1a.
This is a high-yield distinction from Miller Fisher syndrome. Both Miller Fisher syndrome and Bickerstaff brainstem encephalitis can have ophthalmoplegia and ataxia, and both may be associated with anti-GQ1b antibodies. However, Miller Fisher syndrome does not have CNS involvement, whereas Bickerstaff brainstem encephalitis does.
**Table:** Clinical Classification of Guillain-Barré Syndrome (cont'd)
![[857d30e1_medium_table__25__1785000625.png]]
A 6-year-old child was diagnosed with an acute immune-mediated polyradiculoneuropathy after developing progressive limb weakness and areflexia. He received IVIG during the acute illness and gradually improved over the following weeks. At follow-up, the parents ask about expected recovery and long-term prognosis. Which of the following statements is most accurate?
---
- (A) IVIG improves long-term neurological outcome and decreases the severity of residual weakness
- (B) Tendon reflexes are usually the first function to recover
- (C) Demyelinating forms generally recover faster than axonal forms
- (D) Relapses occur in nearly one-third of affected children
💡 Click to Reveal Answer & Nelson Rationale
Option C (Demyelinating forms generally recover faster than axonal forms)
Childhood Guillain-Barré syndrome is usually a monophasic illness. Recovery commonly begins within 2–3 weeks, although complete recovery may take months. IVIG hastens recovery but does not alter the long-term neurological outcome. Most children eventually regain full strength, although a minority may have residual weakness, especially involving ankle dorsiflexors.
Recovery often occurs in the reverse direction of involvement, with bulbar function improving earlier and lower-limb weakness resolving later. Tendon reflexes are usually the last function to recover. Poor prognostic features include cranial nerve involvement, need for ventilatory support, and maximum disability at presentation. Children with demyelinating forms generally recover more quickly than those with axonal forms. Fatigue is the most common long-term residuum, and relapse occurs in only about 4% of children.
What is the most common long-term residuum of Guillain-Barré syndrome in children?
---
- (A) Fatigue
- (B) Residual ankle dorsiflexor weakness
- (C) Residual sensory paresthesias
- (D) Neuropathic pain
💡 Click to Reveal Answer & Nelson Rationale
Option A (Fatigue)
The most common long-term residuum of Guillain-Barré syndrome in children is fatigue. It may persist even after apparent neurological recovery and near-normal power on examination. During the acute illness, as many as 60% of affected children may become nonambulant, but most eventually regain full strength. A minority may have residual weakness, most often involving the ankle dorsiflexors. Therefore, residual ankle dorsiflexor weakness is an important sequela to remember, but fatigue remains the most common long-term residual complaint.
An 11-year-old child develops sudden-onset weakness of the right side of the face. He is unable to close the right eye completely, and the angle of the mouth deviates to the left. Both the forehead and lower face are involved. Otoscopic examination shows no vesicles in the external auditory canal or auricle. There is no hearing loss, limb weakness, other cranial nerve palsy, or brainstem signs. His parents mention that during the previous week he had low-grade fever, malaise, headache, and generalized body aches, which were thought to be a viral illness. Blood pressure is normal. Which etiology should be specifically considered?
---
- (A) Idiopathic Bell palsy due to HSV-1 reactivation
- (B) Lyme-associated facial palsy
- (C) Varicella-zoster–associated facial palsy without vesicles
- (D) Epstein-Barr virus–associated facial palsy
💡 Click to Reveal Answer & Nelson Rationale
Option B (Lyme-associated facial palsy)
This child has an acute lower motor neuron facial nerve palsy, as both the upper and lower parts of the face are involved. At first glance, it resembles idiopathic Bell palsy because it is acute, unilateral, and not associated with brainstem signs or other cranial nerve involvement. However, the subtle clue is the preceding systemic illness with fever, malaise, headache, and body aches. These constitutional symptoms are uncommon in idiopathic Bell palsy and should prompt consideration of Lyme-associated facial palsy, particularly in an appropriate epidemiologic setting. Lyme disease may cause unilateral or bilateral facial nerve palsy.
Idiopathic Bell palsy is an acute-onset peripheral facial palsy and is commonly linked to HSV-1 or varicella-zoster reactivation. Ramsay Hunt syndrome is suggested by facial palsy with painful vesicles in the external auditory canal or auricle. In this case, absence of vesicles makes herpes zoster oticus less likely, while the systemic prodrome favors Lyme disease.
A 5-year-old child presents with acute-onset lower motor neuron facial palsy involving the upper and lower face. There are no vesicles in the ear canal, no other cranial nerve palsy, no brainstem signs, and blood pressure is normal. He is unable to close the affected eye completely. Which is the most important management step in pediatric Bell palsy?
---
- (A) Oral acyclovir
- (B) Corneal protection with ocular lubricant
- (C) MRI of the facial nerve
- (D) Short-term oral corticosteroids
💡 Click to Reveal Answer & Nelson Rationale
Option B (Corneal protection with ocular lubricant)
The most important management step in this child is corneal protection with ocular lubricant, especially at night. In Bell palsy, incomplete eye closure places the child at risk of exposure keratitis, so eye protection is essential regardless of whether corticosteroids are used. Pediatric Bell palsy generally has an excellent outcome, and the benefit of corticosteroids, with or without acyclovir, has not been clearly established, although many centers recommend a brief course of oral prednisone.
A 5-month-old male infant is brought to the emergency department with poor feeding, failure to thrive, and tachypnea. Examination reveals hepatomegaly, hypotonia, and systolic murmur. ECG shows ventricular hypertrophy, and echocardiography reveals dilated cardiomyopathy with left ventricular non-compaction. CBC shows absolute neutrophil count of 300/mm³. Urinalysis shows elevated 3-methylglutaconic acid. The pedigree of inheritance pattern is shown in the image. Which gene mutation could be the most probable cause?
---
- (A) MTM
- (B) RYR1
- (C) TAFAZZIN
- (D) NEB
💡 Click to Reveal Answer & Nelson Rationale
Option C (TAFAZZIN)
The child presents with the classical clinical features of Barth syndrome, a rare X-linked disorder caused by mutations in the TAZ gene. Key manifestations include cardiomyopathy, most notably left ventricular non-compaction (LVNC), which can lead to heart failure or arrhythmias. Neutropenia is another hallmark feature, predisposing the child to recurrent bacterial infections. Skeletal myopathy is commonly seen, presenting as generalized hypotonia and delayed motor milestones during infancy or early childhood. A distinctive biochemical finding in Barth syndrome is the persistent elevation of urinary 3-methylglutaconic acid, which serves as an important diagnostic clue in the metabolic workup of suspected cases. The pedigree shows an X-linked recessive inheritance pattern, where only males are affected and female carriers are typically asymptomatic. This aligns with Barth syndrome, which is caused by mutations in the TAFAZZIN (TAZ) gene located on the X chromosome. TAFAZZIN encodes tafazzin, a mitochondrial transacylase enzyme essential for the remodelling of cardiolipin - a phospholipid critical for maintaining mitochondrial membrane integrity and function, particularly in energy-demanding tissues like cardiac and skeletal muscle. This unique combination of clinical features, biochemical profile, and inheritance pattern strongly supports the diagnosis of Barth syndrome.
An 8-year-old boy is brought for evaluation due to motor delays and poor posture. Parents report that he was hypotonic since infancy but has been walking independently since 2 years of age. He tires quickly, snores at night, and has restless sleep. On examination, he has axial hypotonia, lumbar lordosis, narrow bell-shaped chest, and preserved facial and limb strength. An image taken while attempting to bend forward is shown below: His CK is mildly elevated. Cardiac evaluation is normal. Which of the following gene mutations is most likely responsible for this condition?
---
- (A) LMNA
- (B) SEPN1
- (C) DMD
- (D) COL6A1
💡 Click to Reveal Answer & Nelson Rationale
Option B (SEPN1)
The image shows rigid spine - a hallmark of SEPN1-related myopathy . The SEPN1 gene encodes Selenoprotein N, involved in redox regulation of skeletal muscle and is mutated in Rigid Spine Syndrome. This child presents with the classic features of SEPN1-related - Rigid Spine syndrome. Axial hypotonia is often the earliest sign in infancy or early childhood, distinguishing it from limb girdle myopathies, where proximal limb weakness is more prominent. A hallmark of SEPN1-related disease is progressive spinal rigidity, as highlighted in the attached image: the child attempts to bend forward but is unable to flex the spine. Limb and facial muscle strength are typically preserved, which helps differentiate it from Duchenne muscular dystrophy (DMD) or LMNA-related myopathies that often show more generalized weakness. The thoracic involvement leads to a bell-shaped chest and restrictive lung disease, manifesting as sleep-disordered breathing with symptoms like snoring and restless sleep. Cardiac evaluation is usually normal in SEPN1, helping to rule out LMNA mutations that frequently cause early cardiomyopathy or conduction defects. Serum creatine kinase (CK) is only mildly elevated, helping distinguish SEPN1 from dystrophinopathies such as DMD, where CK levels are typically very high.
A 3-year-old boy presents with delayed motor milestones, hypotonia, and mild facial weakness. He can sit but cannot walk independently. His parents report that he was floppy since infancy. Clinical examination reveals axial weakness and high-arched palate. Electromyography shows a myopathic pattern. Muscle biopsy demonstrates rod-shaped, eosinophilic inclusions in the sarcoplasm on modified Gomori trichrome stain. The electron microscopy of the muscle biopsy shows the following. Genetic testing is ordered to identify the underlying cause. Which of the following genes is most commonly mutated in these patients?
---
- (A) ACTA1
- (B) NEB
- (C) TPM3
- (D) KHL40
💡 Click to Reveal Answer & Nelson Rationale
Option B (NEB)
Nemaline bodies are small, spindle-shaped rods or short thread-like structures primarily distributed in the sarcoplasm. They stain dark purple with Gomori-trichrome. Using electron microscopy, they appear as spindle-shaped electron-dense structures with electron density similar to that of the Z-disks and are often observed in continuation with the Z-disk (as shown in the figure in question). Nemaline myopathy refers to a congenital myopathy characterised by the presence of nemaline rods. However, careful evaluation is necessary to diagnose nemaline myopathy, as the detection of nemaline rods is a nonspecific finding that can also appear in many other conditions, including muscle dystrophies and inflammatory myopathies. Approximately 50% of the patients with nemaline myopathy show mutations in the nebulin (NEB) gene. Nebulin is a very large actin-binding protein that runs along the thin filament from the Z-disc toward the pointed end. Its primary role is to regulate and maintain thin filament length, stabilize actin, and contribute to the contractile function of the sarcomere by influencing the interaction between actin and the troponin–tropomyosin complex. When NEB is mutated, thin filaments become abnormally short and unstable, leading to impaired sarcomere force generation, disrupted length–tension relationships, and subsequent muscle weakness. The pathological accumulation of disorganized Z-line material then manifests as nemaline rods, the diagnostic hallmark of this disease. Clinically, NEB-related nemaline myopathy most often follows an autosomal recessive inheritance pattern. Affected children are typically hypotonic at birth and may be described as “floppy infants.” They later present with delayed motor milestones, axial and proximal muscle weakness, and characteristic craniofacial features including a long thin face, high-arched palate, and facial weakness. Respiratory involvement is common and may be disproportionately severe compared with limb weakness, often necessitating early respiratory monitoring and intervention.
A 3-year-old child is brought for evaluation of severe muscle weakness present since birth. Examination reveals generalized hypotonia, multiple proximal joint contractures (especially elbows and knees), distal joint hyperlaxity in hands and feet, and frequent respiratory infections requiring airway suctioning. The skin shows keratosis pilaris on the arms and legs. Muscle MRI is given below. Which of the following gene mutations is most likely responsible for this condition?
---
- (A) COL6A2
- (B) SEPN1
- (C) RAPSN
- (D) DMD
💡 Click to Reveal Answer & Nelson Rationale
Option A (COL6A2)
The COL6A1, COL6A2, and COL6A3 genes encode the three chains of collagen type VI, a critical component of the extracellular matrix in muscle and connective tissue. Mutations in these genes cause collagen VI-related myopathies, which include Ullrich Congenital Muscular Dystrophy (Ullrich CMD) and Bethlem Myopathy. Muscle MRI findings in Ullrich CMD (given in figure) - Axial T1-weighted images of the upper leg muscles. Note the relative sparing of the central part of the vastus lateralis (white arrows) with a rim of increased signal at the periphery of the muscle consistent with an "outside-in" pattern and the prominent increase in signal intensity in the central part of the rectus femoris (black arrowheads) consistent with a "central cloud" pattern. Ullrich congenital muscular dystrophy (UCMD) and Bethlem congenital muscular dystrophy (Bethlem CMD) are both part of the spectrum of collagen VI–related myopathies, caused by mutations in the COL6A1, COL6A2, or COL6A3 genes. Collagen VI is essential for the structural stability of the extracellular matrix in skeletal muscle. Although the two disorders share a genetic basis, their clinical presentations and natural history are distinct. UCMD typically presents in the neonatal period or infancy with pronounced hypotonia and weakness. Children with UCMD often exhibit proximal joint contractures—in the hips, knees, and elbows—together with distal joint hyperlaxity, giving the paradoxical appearance of stiff proximal joints and overly flexible hands or feet. Many affected children never achieve independent ambulation or lose walking ability early in childhood. Progressive weakness is accompanied by respiratory insufficiency, which frequently necessitates ventilatory support, and characteristic cutaneous features such as velvety skin, follicular hyperkeratosis, and keloid formation are common.
A 6-year-old boy presents with progressive muscle stiffness, short stature, and distinctive facial features including a mask-like expression, blepharophimosis, and micrognathia as shown in the image. His parents report that he has had generalized muscle hypertrophy and a waddling gait since early childhood. On examination, he exhibits generalized myotonia, joint contractures, and normal deep tendon reflexes. Electromyography reveals continuous myotonic discharges at rest. Radiographs show shortened long bones, epiphyseal abnormalities, and scoliosis. Genetic testing confirms a homozygous mutation in the HSPG2 gene.Which of the following is the first-line treatment to alleviate his myotonic symptoms?
---
- (A) Carbamazepine
- (B) Physiotherapy alone
- (C) Botulinum toxin A
- (D) Prednisolone
💡 Click to Reveal Answer & Nelson Rationale
Option A (Carbamazepine)
Schwartz-Jampel Syndrome (SJS) is a rare autosomal recessive disorder caused by mutations in the HSPG2 gene, which encodes perlecan, a heparan sulfate proteoglycan essential for normal neuromuscular junction function and skeletal development. Clinically, SJS presents with progressive myotonia, muscle hypertrophy, joint contractures, short stature, and characteristic facial features such as blepharophimosis, micrognathia, and a mask-like expression. Electromyography typically shows continuous myotonic discharges at rest, and radiographs reveal shortened long bones, epiphyseal abnormalities, and scoliosis. The primary goal of treatment is to reduce abnormal muscle activity, which causes stiffness and cramping. Sodium channel blockers such as carbamazepine is the drug of choice for symptomatic relief. It works by stabilizing the inactivated state of sodium channels, reducing repetitive firing of muscle fibers, and thereby improving muscle relaxation.
A child with distal weakness, pes cavus, distal sensory loss, and absent ankle reflexes undergoes sural nerve biopsy. The biopsy image is shown. Which pathologic finding is demonstrated?
---
## 📖 Reference Citations & Explanations
- (A) Glial filaments (Rosenthal fibers)
- (B) Interstitial hypertrophic neuropathy
- (C) Giant axons
- (D) Focally folded myelin neuropathy
💡 Click to Reveal Answer & Nelson Rationale
Option B (Interstitial hypertrophic neuropathy)
The biopsy image shows onion bulb formations, produced by concentric proliferation of Schwann cell cytoplasm around axons. This is the characteristic pathologic appearance of interstitial hypertrophic neuropathy, classically seen in demyelinating hereditary motor and sensory neuropathies such as Charcot-Marie-Tooth disease. It reflects repeated cycles of segmental demyelination and remyelination. In peroneal muscular atrophy/CMT, sural nerve biopsy may also show reduced large and medium myelinated fibers, increased collagen, and extensive segmental demyelination and remyelination. Nerve conduction velocities are markedly reduced, serum CK is usually normal, and CSF protein may be elevated without pleocytosis.
![[05cd092c_1784800463150_1784800463.png]]